Anders Kvanta
- Ophthalmology top 0.2%
- Retinal Diseases and Treatments 59
- Glaucoma and retinal disorders 23
- Retinal and Optic Conditions 16
- Ocular Diseases and Behçet’s Syndrome 9
-
- Retinal Imaging and Analysis 9
- Physiology top 2%
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 9
- Molecular Biology top 5%
- Retinal Development and Disorders 19
- Angiogenesis and VEGF in Cancer 17
Anders Kvanta
103 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Ophthalmology 2.2k
- Radiology, Nuclear Medicine and Imaging 1.4k
- Physiology 150
- Cancer Research 356
- Molecular Biology 1.6k
Countries citing papers authored by Anders Kvanta
This map shows the geographic impact of Anders Kvanta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Kvanta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Kvanta more than expected).
Fields of papers citing papers by Anders Kvanta
This network shows the impact of papers produced by Anders Kvanta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Kvanta. The network helps show where Anders Kvanta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anders Kvanta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 0 | |
| 8 | 2020 | 71 | |
| 9 | 2020 | 27 | |
| 10 | 2018 | 4 | |
| 11 | 2016 | 38 | |
| 12 | 2016 | 22 | |
| 13 | 2013 | 18 | |
| 14 | 2007 | 13 | |
| 15 | 2007 | 122 | |
| 16 | Decreased Pathologic Retinal Neovascularization in IL–10–Deficient Mice | 2006 | 1 |
| 17 | 2003 | 14 | |
| 18 | Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factorbreakdown → | 1996 | 551 |
| 19 | 1995 | 65 | |
| 20 | 1994 | 35 |
About Anders Kvanta
Anders Kvanta is a scholar working on Ophthalmology, Physiology and Radiology, Nuclear Medicine and Imaging, having authored 104 papers that have together received 3.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (59 papers), Glaucoma and retinal disorders (23 papers), Retinal Development and Disorders (19 papers), Angiogenesis and VEGF in Cancer (17 papers), Retinal and Optic Conditions (16 papers), Retinal Imaging and Analysis (9 papers), Protease and Inhibitor Mechanisms (9 papers) and Ocular Diseases and Behçet’s Syndrome (9 papers). The work is most often cited by research in Ophthalmology (2.2k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations) and Physiology (150 citations). Anders Kvanta has collaborated with scholars based in Sweden, Italy and Spain. Frequent co-authors include Stefan Seregard, Lena Berglin, Björn Steén, Peep V. Algvere, David L. Epstein, Helder André, Bertil B. Fredholm, Pär Gerwins, Branka Samolov and Ingeborg van der Ploeg. Their work appears in journals such as Acta Ophthalmologica, Investigative Ophthalmology & Visual Science, Current Eye Research, Experimental Eye Research and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.